The Cooper's EPS (Basic) for the
three
months ended in Jan. 2024 was $0.41.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was $1.47.
The Cooper's EPS without NRI for the
three
months ended in Jan. 2024 was $0.41.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was $4.84.
During the past 12 months, The Cooper's average EPS without NRIGrowth Rate was 129.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 177.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 73.50% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 23.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, The Cooper's highest 3-Year average EPS without NRI Growth Rate was 178.70% per year. The lowest was -53.90% per year. And the median was 13.25% per year.
The Cooper EPS (Diluted) Historical Data
The historical data trend for The Cooper's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Cooper's EPS (Diluted)
For the Medical Instruments & Supplies subindustry, The Cooper's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's PE Ratio distribution charts can be found below:
* The bar in red indicates where The Cooper's PE Ratio falls into.
The Cooper EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
The Cooper's Diluted EPS for the fiscal year that ended in Oct. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (NAS:COO) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
The Cooper EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of The Cooper's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 